Prime Highlights-
- UAE launches its first gene therapy trial targeting a rare inherited eye disease.
- Treatment aims to fix the root cause of vision loss with no existing cure.
Key Facts-
- The clinical trial, led by the Department of Health – Abu Dhabi, focuses on a genetic eye condition that can lead to severe vision loss or blindness.
- The study follows strict safety rules and tracks patient results, while also supporting future gene-based treatment research.
Background-
Abu Dhabi has started the UAE’s first clinical trial for a gene therapy to treat a rare inherited eye disease. This is an important step in improving healthcare research. The programme has been launched by the Department of Health in Abu Dhabi and aims to find a treatment for a condition that can cause serious vision loss or blindness.
The trial will test a new gene therapy that tries to fix the faulty gene causing the disease. By treating the main cause, it aims to slow down or even stop vision loss. At present, there are very few or no approved treatments for such eye conditions, which makes this development important.
Health officials said the launch of this trial reflects Abu Dhabi’s growing role in supporting innovation and medical research. It also highlights efforts to bring advanced and specialized treatments to patients within the region.
The programme is expected to follow strict safety and regulatory standards while monitoring patient outcomes closely.
Experts say that if the trial works, it could bring new treatments in the UAE and in other countries. It may also lead to more research on gene-based treatments for other genetic diseases.
The trial is still new, results are not known yet, but it gives hope and shows progress in treating inherited eye diseases.
